Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Possible Insufficiency of Generic Price Competition to Contain Prices for Orally Administered Anticancer Therapies.

× No keyword cloud information.

4 in total

Review 1. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.

Authors: Aaron S Kesselheim; Jerry Avorn; Ameet Sarpatwari
Journal: JAMA Date: 2016 Aug 23-30 Impact factor: 56.272

2. Drug Pricing Trends for Orally Administered Anticancer Medications Reimbursed by Commercial Health Plans, 2000-2014.

Authors: Stacie B Dusetzina
Journal: JAMA Oncol Date: 2016-07-01 Impact factor: 31.777

3. Generic Drug Approvals Since the 1984 Hatch-Waxman Act.

Authors: Ravi Gupta; Aaron S Kesselheim; Nicholas Downing; Jeremy Greene; Joseph S Ross
Journal: JAMA Intern Med Date: 2016-09-01 Impact factor: 21.873

4. Steady Increase In Prices For Oral Anticancer Drugs After Market Launch Suggests A Lack Of Competitive Pressure.

Authors: Caroline S Bennette; Catherine Richards; Sean D Sullivan; Scott D Ramsey
Journal: Health Aff (Millwood) Date: 2016-05-01 Impact factor: 6.301

4 in total

2 in total

1. Why individual-level interventions are not enough: Systems-level determinants of oral anticancer medication adherence.

Authors: Lorraine T Dean; Marshalee George; Kimberley T Lee; Kimlin Ashing
Journal: Cancer Date: 2020-05-21 Impact factor: 6.860

2. Perceptions of Health-Care Workers of the Cost and Safety of Oral Oncolytic Agents for Patients: A Survey.

Authors: Madeline Tompkinson; Kelly Fine; Dean Gruber; Ivo Abraham; Ali McBride
Journal: J Adv Pract Oncol Date: 2020-05-01

2 in total